Đang chuẩn bị liên kết để tải về tài liệu:
Long-term real-world experience with ipilimumab and non-ipilimumab therapies in advanced melanoma: The IMAGE study

Ipilimumab has shown long-term overall survival (OS) in patients with advanced melanoma in clinical trials, but robust real-world evidence is lacking. We present long-term outcomes from the IMAGE study (NCT01511913) in patients receiving ipilimumab and/or non-ipilimumab (any approved treatment other than ipilimumab) systemic therapies. |